Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2022 Earnings Call Transcript November 8, 2022
Marinus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.89, expectations were $0.47.
Operator: Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals’ Third Quarter 2022 Financial Results and Business Update Call. And now it’s my pleasure to introduce your host, Sasha Damouni Ellis, Vice President of Corporate Affairs and Investor Relations. You may begin...
